Insider Transactions in Q1 2022 at Inhibikase Therapeutics, Inc. (IKT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2022
|
Milton H. Werner President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,853
+0.41%
|
$43,706
$2.02 P/Share
|